Condition: Preeclampsia Postpartum · Sponsor: MemorialCare Health System
The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have given birth. We hypothesize that taking aspirin for the first week after giving birth will enhance recovery from preeclampsia by decreasing the levels of a protein called soluble fms-like tyrosine kinase (sFlt-1), which is thought to be a main contributor to the development of preeclampsia, and speeding up return to a normal blood pressure.
This description comes directly from the study's public registry record.
Megan C Oakes, MD MSCI · 562-997-8510 · moakes2@memorialcare.org
Ashten B Waks, MD MSPH · 562-997-8510 · awaks@memorialcare.org
Always discuss trial participation with your own doctor first.
| Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach | Long Beach, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05924971